HUM collaborates with Evergreen Nephrology to introduce a specialized care program for chronic kidney disease patients.
Humana (HUM) reported earnings 30 days ago. What's next for the stock?
Johnson Controls stock (NYSE: HUM) currently trades around $70 per share, compared to its peak levels of over $80 seen in January 2022. While the company's stock has shed more than 10% of its value, Carrier stock (NYSE: CARR) has risen around 40% over the same period.
Humana (NYSE: HUM) currently trades around $355 per share, nearly 30% below its peak level of $495 seen in September 2022. In comparison, UnitedHealth stock (NYSE: UNH) saw its stock rise 13% over the same period.
LOS ANGELES, CA / ACCESSWIRE / August 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Humana Inc. ("Humana" or "the Company") (NYSE:HUM) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between July 27, 2022 and January 24, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before August 2, 2024.
NEW YORK, NY / ACCESSWIRE / August 2, 2024 / If you suffered a loss on your Humana Inc. (NYSE:HUM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / August 2, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Humana Inc. ("Humana" or "the Company") (NYSE:HUM) and certain of its officers. Class Definition: This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Humana securities between July 27, 2022 and January 24, 2024, inclusive (the "Class Period").
NEW YORK, NY / ACCESSWIRE / August 2, 2024 / If you suffered a loss on your Humana Inc. (NYSE:HUM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / August 2, 2024 / If you suffered a loss on your Humana Inc. (NYSE:HUM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / August 1, 2024 / If you suffered a loss on your Humana Inc. (NYSE:HUM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / August 1, 2024 / If you suffered a loss on your Humana Inc. (NYSE:HUM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.
NEW YORK, NY / ACCESSWIRE / August 1, 2024 / If you suffered a loss on your Humana Inc. (NYSE:HUM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.